Women’s Health Diagnostics Market
Opportunity Analysis and Industry Forecast, 2016-2023
Global Opportunity Analysis and Industry Forecast, 2016-2023 Global Opportunities and Industry Forecasts, 2017-2023
WOMEN'S HEALTH DIAGNOSTICS MARKET Global Women's Health Diagnostics Market is projected to reach $21,501 million at a CAGR of 7.0% from 2017 to 2023. Gynecology is the main branch of medical science concerned with women's health problems. This includes the health related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity. Rise in geriatric female population, increase in incidence of chronic and lifestyle disorders, demand for point of care diagnostic testing, and high adoption of diagnostics imaging procedures. Moreover, numerous government initiatives to promote women health awareness also drives the market growth. However, the market growth is limited by high cost of diagnostics tests and dearth of skilled professionals. Conversely, surge in demand for the development of miniature diagnostic devices, rise in healthcare infrastructure, and creative marketing initiatives by key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period.
WOMEN'S HEALTH DIAGNOSTICS MARKET Factors such as rise in prevalence of various chronic lifestyle disorders in women, rise in female geriatric population who are more prone to several disorders, increase in adoption of point of care diagnosis, high demand for imaging and diagnosing centers, and support from government in promoting awareness about women related disorders. However, factors such as expensive imaging procedures and lack of skilled professionals restrains the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening and carrier testing include tests for cystic fibrosis and other diseases. The pregnancy and ovulation testing segment is further bifurcated into lab-based pregnancy and ovulation testing, and home-based pregnancy and ovulation testing. Depending on end user, it is categorized into hospitals and clinics, home care settings, diagnostic and imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
WOMEN'S HEALTH DIAGNOSTICS MARKET Key findings of the Women's Health Diagnostics Market: •Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016 •Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023. •Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016 •North America accounted for around 33.7% share of the global women's health diagnostics market in 2016 •Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023 Download Full Sample Report: https://www.alliedmarketresearch.com/request-sample/4521
WOMEN'S HEALTH DIAGNOSTICS MARKET
WOMEN'S HEALTH DIAGNOSTICS MARKET Women's Health Diagnostics Market Key Segments: By Type • Diagnostic Devices • Diagnostic Tests • Breast Cancer Testing • Cervical Cancer Testing • Prenatal Genetic Screening and Carrier Testing • Pregnancy and Ovulation Testing • Ovarian Cancer Testing • Accessories and Consumables
• • • •
By End User Hospitals and Clinics Home Care Settings Diagnostic and Imaging Centers Others
WOMEN'S HEALTH DIAGNOSTICS MARKET
By Region North America Europe Asia-Pacific LAMEA
Do Purchase Report: https://www.alliedmarketresearch.com/purchase-enquiry/4521
WOMEN'S HEALTH DIAGNOSTICS MARKET
Contact: Shriram Dighe 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: +1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1⟨855⟩550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com
WOMEN'S HEALTH DIAGNOSTICS MARKET
Thank You!
For More Details Visit us at https://www.alliedmarketresearch.com/womens-health-diagnostics-market
Follow Us On